Discontinuation report SANDOZ CLOPIDOGREL
| Report ID | 141634 |
| Drug Identification Number | 02359316 |
| Brand name | SANDOZ CLOPIDOGREL |
| Common or Proper name | SANDOZ CLOPIDOGREL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-06-28 |
| Remaining supply date | 2021-06-28 |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | Ventes et profitabilités très faibles |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-06-29 | French | Compare |
| v1 | 2021-06-29 | English | Compare |
Showing 1 to 2 of 2